Sakar Healthcare Secures 14 Oncology Approvals Across EU, UK And Canada

Sakar secured 14 oncology product approvals across the EU, UK and Canada with seven partners. Accord received five additional EMA site-variation approvals, taking its total to six of eight technology transfers, while six licensed-out products gained marketing authorizations. Context: advances the company’s oncology commercialization ramp.